MDG1:FRA
MediGene AG
€0.017
arrow_upward
+3.61%(+0.00060) 1D
Jun 30, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
This Rare Market Signal Has Appeared Only 2 Times in a Century. Here Is What History Says Comes Next.
AOL.com
·
11 hours ago
History Says Coca-Cola Stock Holds Up When the S&P 500 Falls
PR Newswire
·
21 hours ago
Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week
U.S. Global Investors
·
1 day ago
Gold Stumbled in September, but Gold Miners Beat Every Sector in the S&P 500
Profile
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia